CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Trial Comparing ARA-C/High-Dose Mitoxantrone ("ALL-2') to A Standard Vincristine/Prednisone Based Regimen ('L-20') as Induction Therapy For Adult Patients With Acute Lymphoblastic Leukemia (ALL): The ALL-4 Protocol

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00002766
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:59.845416+00:00
Published At: 2016-02-22T00:00:00+00:00
Record Updated At: 2016-02-22
Results Posted At: 2016-02-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia", "Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-02-22"
protocolSection.identificationModule.nctId: "NCT00002766"
protocolSection.identificationModule.officialTitle: "A Phase III Trial Comparing ARA-C/High-Dose Mitoxantrone (\"ALL-2\u0027) to A Standard Vincristine/Prednisone Based Regimen (\u0027L-20\u0027) as Induction Therapy For Adult Patients With Acute Lymphoblastic Leukemia (ALL): The ALL-4 Protocol"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-02-22"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.